Standardization of Antiphospholipid antibody testing-historical perspectives and ongoing initiatives

Seminars in Thrombosis and Hemostasis

Volumn 40, Issue 2, 2014, Pages 172-177

  Willis, Rohan ^a   Lakos, Gabriella ^b   Harris, E Nigel ^c  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b INOVA DIAGNOSTICS INC   (United States)

^c UNIVERSITY OF THE WEST INDIES   (Jamaica)

Author keywords

anti 2 glycoprotein I antibodies; anticardiolipin antibodies; antiphospholipid antibodies; standardization

Indexed keywords

BETA2 GLYCOPROTEIN 1; BETA2 GLYCOPROTEIN 1 ANTIBODY; GELATIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PHOSPHATE BUFFERED SALINE; PHOSPHOLIPID ANTIBODY; CARDIOLIPIN ANTIBODY;

BINDING AFFINITY; CALIBRATION; CALIBRATOR; ENZYME LINKED IMMUNOSORBENT ASSAY; FEEDBACK SYSTEM; FETAL CALF SERUM; HEPATITIS C; HUMAN; HYBRIDOMA; IMMUNE DEFICIENCY; INCUBATION TIME; INTERNATIONAL STANDARD UNIT; MORBIDITY; OPTICAL DENSITY; POPULATION; PREGNANCY; PRIORITY JOURNAL; QUESTIONNAIRE; RADIOIMMUNOASSAY; REVIEW; RISK FACTOR; STANDARDIZATION; SYPHILIS; TASK PERFORMANCE; TEMPERATURE; THROMBOSIS; VALIDATION STUDY; ANTIPHOSPHOLIPID SYNDROME; IMMUNOASSAY; IMMUNOLOGY; MASS SCREENING; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STANDARD; STANDARDS;

ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; BETA 2-GLYCOPROTEIN I; HUMANS; IMMUNOASSAY; MASS SCREENING; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84896740262     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0033-1364207     Document Type: Review

References (40)

1. Miyakis S., Lockshin M. D., Atsumi T., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost: 2006; 4 2 295 306
2. Tincani A., Allegri F., Balestrieri G., et al. Minimal requirements for antiphospholipid antibodies ELISAs proposed by the European Forum on antiphospholipid antibodies. Thromb Res: 2004; 114 5-6 553 558
3. Wong R. CW, Gillis D., Adelstein S., et al. Consensus guidelines on anti-cardiolipin antibody testing and reporting. Pathology: 2004; 36 1 63 68
4. Wong R. C., Favaloro E. J., Adelstein S., et al. Consensus guidelines on anti-beta 2 glycoprotein I testing and reporting. Pathology: 2008; 40 1 58 63
5. Wong R. C., Adelstein S., Gillis D., Favaloro E. J. Development of consensus guidelines for anticardiolipin and lupus anticoagulant testing. Semin Thromb Hemost: 2005; 31 1 39 48
6. 2-glycoprotein I antibodies. Standardization group of the European Forum on Antiphospholipid Antibodies. J Thromb Haemost: 2004; 2 10 1860 1862
7. Reber G., Schousboe I., Tincani A., et al. Inter-laboratory variability of anti-beta2-glycoprotein I measurement. A collaborative study in the frame of the European Forum on Antiphospholipid Antibodies Standardization Group. Thromb Haemost: 2002; 88 1 66 73
8. Wong R. CW, Favaloro E. J., Pollock W., et al. A multi-centre evaluation of the intra-assay and inter-assay variation of commercial and in-house anti-cardiolipin antibody assays. Pathology: 2004; 36 2 182 192
9. Favaloro E. J., Silvestrini R., Mohammed A. Clinical utility of anticardiolipin antibody assays: high inter-laboratory variation and limited consensus by participants of external quality assurance programs signals a cautious approach. Pathology: 1999; 31 2 142 147
10. Lakos G., Favaloro E. J., Harris E. N., et al. International consensus guidelines on anticardiolipin and anti-β2-glycoprotein I testing: report from the 13th International Congress on Antiphospholipid Antibodies. Arthritis Rheum: 2012; 64 1 1 10
11. Harris E. N., Gharavi A. E., Boey M. L., et al. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet: 1983; 2 8361 1211 1214
12. Levine S. R., Salowich-Palm L., Sawaya K. L., et al. IgG anticardiolipin antibody titer > 40 GPL and the risk of subsequent thrombo-occlusive events and death. A prospective cohort study. Stroke: 1997; 28 9 1660 1665
13. Harris E. N., Chan J. K., Asherson R. A., Aber V. R., Gharavi A. E., Hughes G. R. Thrombosis, recurrent fetal loss, and thrombocytopenia. Predictive value of the anticardiolipin antibody test. Arch Intern Med: 1986; 146 11 2153 2156
14. Harris E. N., Gharavi A. E., Patel S. P., Hughes G. RC. Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986. Clin Exp Immunol: 1987; 68 1 215 222
15. Harris E. N. Special report. The Second International Anti-cardiolipin Standardization Workshop/the Kingston Anti-Phospholipid Antibody Study (KAPS) group. Am J Clin Pathol: 1990; 94 4 476 484
16. Ichikawa K., Tsutsumi A., Atsumi T., et al. A chimeric antibody with the human gamma1 constant region as a putative standard for assays to detect IgG beta2-glycoprotein I-dependent anticardiolipin and anti-beta2-glycoprotein I antibodies. Arthritis Rheum: 1999; 42 11 2461 2470
17. Ichikawa K., Khamashta M. A., Koike T., Matsuura E., Hughes G. R. beta 2-glycoprotein I reactivity of monoclonal anticardiolipin antibodies from patients with the antiphospholipid syndrome. Arthritis Rheum: 1994; 37 10 1453 1461
18. Pierangeli S. S., Harris E. N. A quarter of a century in anticardiolipin antibody testing and attempted standardization has led us to here, which is? Semin Thromb Hemost: 2008; 34 4 313 328
19. Sène D., Piette J. C., Cacoub P. [Antiphospholipid antibodies, antiphospholipid syndrome and viral infections]. Rev Med Interne: 2009; 30 2 135 141
20. Galli M., Comfurius P., Maassen C., et al. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet: 1990; 335 8705 1544 1547
21. McNeil H. P., Simpson R. J., Chesterman C. N., Krilis S. A. Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci U S A: 1990; 87 11 4120 4124
22. Harris E. N. Antiphospholipid antibodies. Br J Haematol: 1990; 74 1 1 9
23. Arvieux J., Roussel B., Jacob M. C., Colomb M. G. Measurement of anti-phospholipid antibodies by ELISA using beta 2-glycoprotein I as an antigen. J Immunol Methods: 1991; 143 2 223 229
24. Iverson G. M., Matsuura E., Victoria E. J., Cockerill K. A., Linnik M. D. The orientation of beta2GPI on the plate is important for the binding of anti-beta2GPI autoantibodies by ELISA. J Autoimmun: 2002; 18 4 289 297
25. 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J Exp Med: 1994; 179 2 457 462
26. Roubey R. A., Eisenberg R. A., Harper M. F., Winfield J. B. Anticardiolipin autoantibodies recognize β 2-glycoprotein I in the absence of phospholipid. Importance of Ag density and bivalent binding. J Immunol: 1995; 154 2 954 960
27. Sammaritano L. R., Lockshin M. D., Gharavi A. E. Antiphospholipid antibodies differ in aPL cofactor requirement. Lupus: 1992; 1 2 83 90
28. Chamley L. W., Pattison N. S., McKay E. J. Anomalous anticardiolipin antibody results may be due to cofactor variability. Am J Hematol: 1991; 37 4 289
29. Schlame M., Haller I., Sammaritano L. R., Blanck T. J. Effect of cardiolipin oxidation on solid-phase immunoassay for antiphospholipid antibodies. Thromb Haemost: 2001; 86 6 1475 1482
30. Arvieux J., Darnige L., Hachulla E., Roussel B., Bensa J. C., Colomb M. G. Species specificity of anti-beta 2 glycoprotein I autoantibodies and its relevance to anticardiolipin antibody quantitation. Thromb Haemost: 1996; 75 5 725 730
31. Favaloro E. J., Wheatland L., Jovanovich S., Roberts-Thomson P., Wong R. CW. Internal quality control and external quality assurance in testing for antiphospholipid antibodies: part I-anticardiolipin and anti-β2- glycoprotein I antibodies. Semin Thromb Hemost: 2012; 38 4 390 403
32. Lakos G. Analytical detection capabilities of immunoassay-based antiphospholipid antibody tests: do they matter? Drug Dev Res Drug Development Research: 2013; 74 575 581
33. Harris E. N., Pierangeli S., Birch D. Anticardiolipin wet workshop report. Fifth International Symposium on antiphospholipid antibodies. Am J Clin Pathol: 1994; 101 5 616 624
34. Pierangeli S. S., de Groot P. G., Dlott J., et al. 'Criteria' aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, Texas, April 2010. Lupus: 2011; 20 2 182 190
35. Pierangeli S. S., Favaloro E. J., Lakos G., et al. Standards and reference materials for the anticardiolipin and anti-β2glycoprotein I assays: a report of recommendations from the APL Task Force at the 13th International Congress on Antiphospholipid Antibodies. Clin Chim Acta: 2012; 413 1-2 358 360
36. Willis R., Grossi C., Borghi M. O., et al. Establishment of Standardized International Units for IgG Anti-β2glycoprotein Antibody Measurement. Arthritis Rheum: 2012; 64 (S10): s1033 (abstract 2455)
37. Willis R., Grossi C., Borghi M. O., et al. Establishment of Standardized International Units for IgM Anti-β2glycoprotein Antibody Measurement. Arthritis Rheum: 2013; 65 (S10): s1 (abstract 15)
38. Grossi C., Borghi M. O., Willis R., et al. Evaluation of monoclonal antibodies as reference material for IgG anti-β2glycoprotein I antibody measurement (abstract); September 2013; 14th International Congress on Antiphospholipid Antibodies
39. Escalante A., Brey R. L., Mitchell B. D. Jr, Dreiner U. Accuracy of anticardiolipin antibodies in identifying a history of thrombosis among patients with systemic lupus erythematosus. Am J Med: 1995; 98 6 559 565
40. Devreese K. M., Van Hoecke F. Anticardiolipin and anti- β2glycoprotein-I antibody cut-off values in the diagnosis of antiphospholipid syndrome: more than calculating the in-house 99th percentiles, even for new automated assays. Thromb Res: 2011; 128 6 598 600